If Tumors Could Talk

Oct 23, 2019 | Episode 54 | 22 mins

Cancer is one of the leading causes of death around the world, and 38% people will be diagnosed with cancer at some point in their lives. Listen to Dr. Ramanuj DasGupta and Dr. Shumei Chia of the Genome Institute of Singapore describe how patient-derived tumor models and NGS can combine to offer new insights in precision oncology.

Audio Player

00:00

Download or subscribe to our recurring podcasts.

Apple Podcasts Google Podcasts Spotify RSS

For every lab, everywhere

Illumina Single Cell 3' RNA Prep

NGS Workflow Finder

DRAGEN v4.3 now available on-premises and on-cloud

Illumina Proactive Instrument Performance Service

Do more, faster than ever

Next-generation sequencing for beginners

Next-generation sequencing for beginners

Next-generation sequencing for beginners

Next-generation sequencing for beginners

Next-generation sequencing for beginners

Next-generation sequencing for beginners

Next-generation sequencing for beginners

Celebrate DNA Day with Your Students

Celebrate DNA Day with Your Students

Celebrate DNA Day with Your Students

Celebrate DNA Day with Your Students

Celebrate DNA Day with Your Students

Celebrate DNA Day with Your Students

Celebrate DNA Day with Your Students

For every lab, everywhere

For every lab, everywhere

For every lab, everywhere

For every lab, everywhere

For every lab, everywhere

For every lab, everywhere

If Tumors Could Talk

The Illumina Genomics Podcast

If Tumors Could Talk

Related Episodes

Developmental Biology Meets Immunotherapy

Comprehensive Genomic Tumor Profiling

Genomic Tumor Profiling and Precision Oncology

Download or subscribe to our recurring podcasts.